Picture of Theratechnologies logo

TH Theratechnologies News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Brief: Theratechnologies Receives January 2024 PDUFA Goal Date For Tesamorelin F8 Formulation Sbla

Oct 4 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES RECEIVES JANUARY 2024 PDUFA GOAL DATE
FOR
TESAMORELIN F8 FORMULATION SBLA
    * THERATECHNOLOGIES INC - FDA ASSIGNED PDUFA GOAL DATE OF
JANUARY
22, 2024 TO CO'S SBLA OF F8 FORMULATION OF TESAMORELIN

Source text for Eikon:  ID:nGNX4x45j3 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Theratechnologies

See all news